Back
GT Biopharma Stock Price Chart
Sponsored
GTBP
Sponsored
Forget Bitcoin - This Is the Real Opportunity of 2024
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
44
GTBP
GT Biopharma
Last Price:
2.11
Seasonality Move:
0.04%
7 Day Trial
ALL ACCESS PASS
$
7
The Fed Just Cut Rates-Here's Alex Green's $1 Million AI Stock Picks
Watch Alex Green's breakdown and discover the next big AI winners!- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GTBP is experiencing slight buying pressure.
GT Biopharma Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.07 | Buy |
20-day SMA: | 2.1 | Buy |
50-day SMA: | 2.28 | Sell |
200-day SMA: | 3.98 | Sell |
8-day EMA: | 2.08 | Buy |
20-day EMA: | 2.12 | Buy |
50-day EMA: | 2.32 | Sell |
200-day EMA: | 4.87 | Sell |
GT Biopharma Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.06 | Sell |
Relative Strength Index (14 RSI): | 48 | Sell |
Chaikin Money Flow: | 722 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.04 - 2.2) | Sell |
Bollinger Bands (100): | (1.99 - 3.57) | Sell |
GT Biopharma Technical Analysis
Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for GT Biopharma Stock
Is GT Biopharma Stock a Buy?
- GT Biopharma share price is 2.12 while GTBP 8-day simple moving average is 2.07, which is a Buy signal.
- The stock price of GTBP is 2.12 while GT Biopharma 20-day SMA is 2.10, which makes it a Buy.
- GT Biopharma 50-day simple moving average is 2.28 while GTBP share price is 2.12, making it a Sell technically.
- GTBP stock price is 2.12 and GT Biopharma 200-day simple moving average is 3.98, creating a Sell signal.
GTBP Technical Analysis vs Fundamental Analysis
Sell
44
GT Biopharma (GTBP)
is a Sell
Is GT Biopharma a Buy or a Sell?
-
GT Biopharma stock is rated a Sell
The current GT Biopharma [GTBP] share price is $2.12. The Score for GTBP is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
GT Biopharma Stock Info
Market Cap:
4.74M
Price in USD:
2.12
Share Volume:
5.81K
GT Biopharma 52-Week Range
52-Week High:
10.66
52-Week Low:
1.92
Sell
44
GT Biopharma (GTBP)
is a Sell
GT Biopharma Share Price Forecast
-
What is the GT Biopharma stock price today?
The GT Biopharma stock price is 2.12 USD today. -
Will GTBP stock go up or go down?
GT Biopharma> share price is forecast to RISE/FALL based on technical indicators -
Is GT Biopharma overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, GT Biopharma is overvalued.
Is GT Biopharma Stock a Buy?
- GT Biopharma share price is 2.12 while GTBP 8-day exponential moving average is 2.08, which is a Buy signal.
- The stock price of GTBP is 2.12 while GT Biopharma 20-day EMA is 2.12, which makes it a Buy.
- GT Biopharma 50-day exponential moving average is 2.32 while GTBP share price is 2.12, making it a Sell technically.
- GTBP stock price is 2.12 and GT Biopharma 200-day simple moving average is 4.87, creating a Sell signal.
Fundamental Analysis of GT Biopharma
Is GT Biopharma a good investment?
- Analysts estimate an earnings decrease this quarter of $3.21 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.43 per share, and a decrease next year of $0.00 per share.
Technical Analysis of GT Biopharma
Should I short GT Biopharma stock?
- GTBP Moving Average Covergence Divergence (MACD) indicator is -0.06, suggesting GT Biopharma is a Sell
- GT Biopharma Relative Strength Index (RSI) is 48, which suggest GT Biopharma is oversold
- The Bollinger Bands (25) for GT Biopharma is (2.04 - 2.2), which suggest GT Biopharma is a Sell
- The Bollinger Bands (100) for GT Biopharma is (1.99 - 3.57), which suggest GT Biopharma is a Sell
* GT Biopharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.